Literature DB >> 24817466

Long segment recanalization and dedicated central venous stenting in an ultimate attempt to restore vascular access central vein outflow.

Rick de Graaf1, Jorinde van Laanen, Anna Sailer, Jan Tordoir.   

Abstract

PURPOSE: Maintaining vascular access in patients undergoing chronic hemodialysis is a challenging process, especially in patients enduring multiple central line placements and in whom peripheral options have been exhausted. CASE: We present a case of a 60-year-old male without options for peripheral vascular access due to multiple failed arteriovenous fistulas for hemodialysis. Furthermore, bilateral subclavian, brachiocephalic veins and iliac veins were occluded or significantly obstructed. After long segment central vein recanalization, an upper arm loop arteriovenous graft was implanted. The recanalized segment was stented with a 12-mm dedicated venous nitinol stent.
CONCLUSION: Chronic central vein obstructions demand stents with both high radial force and flexibility. We recommend dedicated venous stents to improve technical success and reduce stent-related complications like early re-occlusion due to fracturing, kinking or straightening.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24817466     DOI: 10.5301/jva.5000251

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  2 in total

1.  Investigation of adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents in the iliac vein: insights into developing a better iliac vein stent.

Authors:  Takuya Shida; Mitsuo Umezu; Kiyotaka Iwasaki
Journal:  J Artif Organs       Date:  2018-02-06       Impact factor: 1.731

2.  The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients.

Authors:  Yonghui Huang; Bing Chen; Guosheng Tan; Gang Cheng; Yi Zhang; Jiaping Li; Jianyong Yang
Journal:  BMC Cardiovasc Disord       Date:  2016-12-07       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.